DBTX - Decibel Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DBTX is currently covered by 3 analysts with an average price target of $11.83. This is a potential upside of $6.92 (140.94%) from yesterday's end of day stock price of $4.91.

Decibel Therapeutics's activity chart (see below) currently has 11 price targets and 12 ratings on display. The stock rating distribution of DBTX is 33.33% BUY and 66.67% HOLD.

Stock Analyst Price Targets - Review

Highest price target for DBTX is $5, Lowest price target is $4, average price target is $11.83.

Most recent stock forecast was given by JACK ALLEN from BAIRD on 10-Aug-2023. First documented stock forecast 09-Mar-2021.

Best performing analysts who are covering DBTX - Decibel Therapeutics:

Mani Foroohar Joseph Pantginis Jack Allen Matthew Luchini Gena Wang

Currently out of the existing stock ratings of DBTX, 1 are a BUY (33.33%), 2 are a HOLD (66.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$5.25

$0.34 (6.92%)

$21

1 years 6 months 3 days ago
(10-Aug-2023)

0/2 (0%)

$0.09 (1.74%)

Hold

$23

1 years 6 months 4 days ago
(09-Aug-2023)

0/1 (0%)

$15.49 (206.26%)

Buy

$2

$-2.91 (-59.27%)

$7

1 years 10 months 29 days ago
(15-Mar-2023)

0/5 (0%)

$-1.51 (-43.02%)

Buy

$7

$2.09 (42.57%)

$30

2 years 10 months 23 days ago
(21-Mar-2022)

0/2 (0%)

$3.97 (131.02%)

Buy

$24

$19.09 (388.80%)

3 years 6 months 3 days ago
(11-Aug-2021)

0/1 (0%)

$16.54 (221.72%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DBTX (Decibel Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on DBTX (Decibel Therapeutics) with a proven track record?

MANI FOROOHAR

Which analyst has the current lower performing score on DBTX (Decibel Therapeutics) with a proven track record?

GENA WANG

Which analyst has the most public recommendations on DBTX (Decibel Therapeutics)?

Mani Foroohar works at LEERINK and has 11 price targets and 8 ratings on DBTX

Which analyst is the currently most bullish on DBTX (Decibel Therapeutics)?

Matthew Luchini with highest potential upside - $19.09

Which analyst is the currently most reserved on DBTX (Decibel Therapeutics)?

Mani Foroohar with lowest potential downside - -$2.91

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?